Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance.
about
Animal models to study acute and chronic intestinal inflammation in mammalsGut microbiota and immune crosstalk in metabolic diseaseNod2 and Nod2-regulated microbiota protect BALB/c mice from diet-induced obesity and metabolic dysfunction.Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk.Gut microorganisms as promising targets for the management of type 2 diabetes.Host Genetic Control of the Microbiota Mediates the Drosophila Nutritional PhenotypeActivation of Kupffer Cells Is Associated with a Specific Dysbiosis Induced by Fructose or High Fat Diet in MiceDifferent Th17 immunity in gut, liver, and adipose tissues during obesity: the role of diet, genetics, and microbesHigh-intensity exercise training increases the diversity and metabolic capacity of the mouse distal gut microbiota during diet-induced obesity.The Microbiota Determines Susceptibility to Experimental Autoimmune UveoretinitisNod2: The intestinal gate keeper.High-fat diet modifies the PPAR-γ pathway leading to disruption of microbial and physiological ecosystem in murine small intestine.Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism.Innate immunity in diabetes and diabetic nephropathy.Tyrosine kinase inhibitors of Ripk2 attenuate bacterial cell wall-mediated lipolysis, inflammation and dysglycemia.Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure.Immunologic impact of the intestine in metabolic disease.NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patients.Microbial Factors in Inflammatory Diseases and Cancers.Intestinal Ralstonia pickettii augments glucose intolerance in obesity.Exclusive Enteral Nutrition Induces Remission in Pediatric Crohn's Disease via Modulation of the Gut Microbiota.Three months of Western diet induces small intestinal mucosa alteration in TLR KO mice.Gut Microbiota Dysbiosis Drives and Implies Novel Therapeutic Strategies for Diabetes Mellitus and Related Metabolic Diseases.The NLRP3 inflammasome contributes to sarcopenia and lower muscle glycolytic potential in old mice.Peptidoglycan recognition by the innate immune system.NOD2 and inflammation: current insights.Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese miceLong term but not short term exposure to obesity related microbiota promotes host insulin resistanceRaspberry Polyphenolic Extract Regulates Obesogenic Signals in Hepatocytes
P2860
Q26777430-D874D955-9B99-4264-9EC3-20C2C5023281Q28078180-013B2C99-61E8-4B37-AA7C-8FF879C44874Q33671877-F71B7369-69EA-42B0-A65F-A5922B936E9AQ35685937-7CC6DEDB-57E9-4FD4-853A-5EBA9E859FD9Q35725065-C68AAE6E-22B7-46A7-A97C-9EF25A390E6CQ35841229-593B70E3-2B0A-40D7-8158-45B34E6B57DFQ35885676-9AAB6A7B-B211-4680-BFF4-34B34BA649BEQ35945260-FC85ACDF-2DF0-4251-8664-373341D5B987Q35999905-8710FF26-30A5-44B0-BF94-338A6D6D5159Q36050092-C51DE18B-E63F-4546-BFBA-494EB881C435Q36295438-D5938A57-8B55-4965-9170-DC88A34207E8Q37323213-FC968C8C-3CB2-4861-A551-54303A4BAC4FQ37727703-3190EEBD-7F67-402A-9D62-132C6AECE9D7Q38633495-B8AB8487-FBF8-47A5-A8C2-5E6C32D3EFA9Q38796867-DE31D105-AFF9-45C4-968E-B02757FCCC2EQ38979963-56952E3A-686D-4914-B1AF-1D7B0F71CAB9Q39065615-810FF1C4-EFAF-49BF-AB2C-985B2165CD50Q40110488-E1EBA54A-769E-4B20-9349-7F403CD2535DQ41997065-315A76E4-0364-41F9-933F-34A547C26190Q46256007-D5367E24-AE00-4AED-B5F2-557B10FEEA8CQ47108484-1206C042-F3ED-4841-9E63-FE192BD56E6CQ48346437-973B5AF9-F6F7-4D67-AA77-CBCCAB87A145Q49769640-54E8F102-4A44-46EE-A194-1F7D42A7C66BQ50985315-C9FD3CAC-8820-4034-AFE3-3CA44201D066Q52732929-2E7E5CE7-BE55-4D01-80FC-B9D8A0E94BC1Q55000637-4C448CDC-2534-4A10-A1D4-368BF2B128B0Q57799919-8E0D853D-8DB8-4A96-A565-DEACC1C4DC47Q58586510-B9B42416-C4EC-4EAB-926A-652F86447289Q58696497-A3027AF7-6C52-4859-9680-851F8839C7D3
P2860
Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Defective NOD2 peptidoglycan s ...... iosis, and insulin resistance.
@ast
Defective NOD2 peptidoglycan s ...... iosis, and insulin resistance.
@en
type
label
Defective NOD2 peptidoglycan s ...... iosis, and insulin resistance.
@ast
Defective NOD2 peptidoglycan s ...... iosis, and insulin resistance.
@en
prefLabel
Defective NOD2 peptidoglycan s ...... iosis, and insulin resistance.
@ast
Defective NOD2 peptidoglycan s ...... iosis, and insulin resistance.
@en
P2093
P2860
P50
P356
P1476
Defective NOD2 peptidoglycan s ...... iosis, and insulin resistance.
@en
P2093
Alexia Zakaroff-Girard
Amanda J Lee
Anne Bouloumié
Brandyn D Henriksbo
Brittany M Duggan
Celine Pomie
Chantal Chabo
Céline Garret
Elodie Luche
Emmanuel Denou
P2860
P304
P356
10.15252/EMMM.201404169
P577
2015-02-09T00:00:00Z